Jump to:
loading...| Preferred Name |
ensituximab |
| Synonyms |
NEO-102 |
| ID |
http://purl.bioontology.org/ontology/MESH/C000619852 |
| altLabel |
NEO-102 NPC-1C |
| cui |
C4507351 C2983727 C4317219 |
| HM |
D000911 |
| Inverse of RB |
F988K568V2 |
| Mapped to | |
| MDA |
20170603 |
| MeSH Frequency |
2 |
| MMR |
20191031 |
| notation |
C000619852 |
| prefLabel |
ensituximab |
| SC |
1 |
| Scope Statement |
targets an MUC5AC variant for treatment of refractory pancreatic and colorectal cancer |
| SRC |
Cancer Chemother Pharmacol. 2016 Sep;78(3):577-84. |
| TERMUI |
T000965915 T000926104 T000926103 |
| TH |
NLM (2017) USAN (19XX) INN (19XX) NLM (2020) |
| tui |
T116 T129 T121 |
Create New Mapping
| Delete | Mapping To | Ontology | Source |
|---|---|---|---|
| http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C90532 | National Cancer Institute Thesaurus / 美国国家癌症研究所词典 | LOOM |